首页 | 本学科首页   官方微博 | 高级检索  
     

β1受体反义基因治疗对肾性高血压大鼠心脏的保护作用
引用本文:伍远雄,王晋明,张美春,梁远红. β1受体反义基因治疗对肾性高血压大鼠心脏的保护作用[J]. 金属学报, 2005, 10(10): 1123-1127
作者姓名:伍远雄  王晋明  张美春  梁远红
作者单位:武汉大学人民医院心内科, 武汉 430060, 湖北;1.武汉湖北省总队医院心内科, 武汉 430061, 湖北
摘    要:目的: 探讨阳离子脂质体混合物介导的β1受体反义基因对肾性高血压大鼠血压和心脏的影响及机制。方法: 将24只雄性SD大鼠随机分成4组(n=6):两肾一夹模型组(2K1C组),两肾一夹模型+反义核苷酸组(尾静脉β1-AS-ODN 0.5 mg·kg-1,反义组),两肾一央模型+反向核苷酸组(尾静脉β1-IN-ODN 0.5 mg·kg-1,反 向组),假手术组。常规方法测定尾动脉收缩压、左室血流动力学指标及左心室重量指数(LVMI),以光镜观察心肌组织变化,免疫组织化学方法检测心肌Bcl-2、 Bax的表达。结果: 单剂反义寡核苷酸治疗可持续降压27 d,血压最低可降至120 mmHg左右;并可明显改善左室收缩、舒张功能;反义组的左室重量指数也显著低于2K1C组(P<0.01);心肌细胞病理变化也较2K1C 组改善;2K1C组心肌Bcl-2/Bax比值明显低于假手术组,而反义组与2K1C组相比,Bcl-2/Bax比值明显升高 (P<0.05)。结论: 以β受体为靶基因的反义基因单剂治疗在有效而持久的控制肾性高血压的同时,可显著逆转左室肥厚,改善左室功能,其机制可能与升高Bcl-2/Bax比值、抑制心肌细胞凋亡相关。说明β受体反义基因治疗对肾性高血压大鼠具有心脏保护作用。

关 键 词:肾性高血压  反义寡核苷酸  β1肾上腺素能受体  基因治疗  左室肥厚  心脏保护  凋亡Bel-2/Bax  
收稿时间:2005-07-16
修稿时间:2005-09-09

Protection effect of β1 receptor mRNA antisense inhibition on heart of renal hypertensive rats
Wuyuan-xiong,WANG Jin-ming,ZHANG Mei-chun,LIANG Yuan-hong. Protection effect of β1 receptor mRNA antisense inhibition on heart of renal hypertensive rats[J]. Acta Metallurgica Sinica, 2005, 10(10): 1123-1127
Authors:Wuyuan-xiong  WANG Jin-ming  ZHANG Mei-chun  LIANG Yuan-hong
Affiliation:Department of Cardiology, Rennin Hospital, Wuhan University, Wuhan 43006, Huei, China
Abstract:AIM: To explore the effect and mechanism on blood pressure and heart protection of renal hypertension in rats treated with β1 receptor antisense oli-godeoxynucleotides (β1-AS-ODN) by delivery with cation-icliposomes DOTAP/DOPE.METHODS: 24 SD rats were divided randomly into 4 groups of 6 each group two groups of 2KIC rats were treated via tail vein injection with β1-AS-ODN or inverted oli gonucleotides against rat β1-AR MNA (β1-IN-ODN) of 0.5 mg·kg-1 once. 6 unltreated 2K1C rats and shamed rats served as positive andnormal controls. Blood pressure (BP), cardiac haemodynamics, and left ventricular index (LVW/BW) were measured. The histological changes of myocardium were observed by optical microscope and the expressions of Bcl-2 and Bax in myocardium were examined by immunohistochemical method.RESULTS: The single dose management of β1-AS-ODN decreased blood pressure to 120 mm-Hg for 27 days and improved the LV function obviously P < 0.01). The value of LVW/BW in β1-AS-ODN oup is much less than the value of that in 2K1C group(P 0.01). Compared with that of 2K1C group, thethological changes of myocardium inβ1-AS-ODN groupmeliorated. The radio of bcl-2/Bax in 2KIC group wasless than sham group, and the radio of that in β1-AS-ODN group was more than 2KIC group (P < 0. 05).CONCLUSION: β1 receptor antisense oligodeoxynucleotidescan maintain anti-hypertension effect for atime and improve LV function, effectively reverses left ventricular hypertrophy in 2K1C renal hypertensive rats. The mecha-nism of which may be related to the suppressing of cell apoptosis of myocardium by increasing Bcl-2/Bax. It sug-gests that, receptor mRNA antisense had the heart protection effect in renal hypertensive raf.
Keywords:renal hypertension  antisense oligonucleotides  β1-adrenergic receptor  gene therapy  left ventricular hypertrophy  heart protection  apotosis  Bcl-2/Bax  
点击此处可从《金属学报》浏览原始摘要信息
点击此处可从《金属学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号